Feature

COPD Clinical Trials at Temple Lung Center

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the Temple Lung Center offers access to clinical trials evaluating new pharmacologic, device-based, and comprehensive treatment approaches.

  • By

  • February 19, 2026

  • 2 min

Share

Chronic obstructive pulmonary disease (COPD) significantly impacts patient quality of life, with many individuals experiencing persistent symptoms despite optimal treatment. The Temple Lung Center, as a leading research institution, offers clinical trials focusing on innovative pharmacologic and device-based therapies aimed at enhancing lung function and patient outcomes. Their multidisciplinary team assesses each patient to match them with suitable trials, ensuring access to emerging therapies that may not be available elsewhere. Interested patients can easily inquire about ongoing studies through provided contact information.

Original Source(s)

COPD Clinical Trials at Temple Lung Center

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the Temple Lung Center offers access to clinical trials evaluating new pharmacologic, device-based, and comprehensive treatment approaches.

  • by

  • February 19, 2026

  • 2 min

Related Content

Chronic Cough Despite Normal Workup

Researchers describe diagnostic evaluation and management considerations when standard testing fails to identify the cause of persistent cough.

2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management

  • by

  • December 21, 2025

  • 3 min
New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.